Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis

Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories

Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort

Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test

Improving Patient Outcomes through a Comprehensive Care Management Platform Measuring Outcomes and Value: an Integrated, Novel solution for Generating insights in MS (MOVING MS)

BrainGraph: A Novel Visualization of MRI Data as a 3D Graph to Reveal Temporal Features of Disease Progression In Patients with Multiple Sclerosis

High throughput lesion evaluation and quality control for incorporating quantitative imaging metrics into clinical practice

Multivariate protein biomarker models more accurately predict multiple sclerosis MRI disease activity compared to serum levels of neurofilament light chain alone

Classification of high versus low annualized relapse rate status in subjects with relapsing-remitting multiple sclerosis using multivariate serum protein biomarker models

1 6 7 8 9

Association Between Serum Biomarkers and Patient-Reported Outcome of Disability in Multiple Sclerosis

Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test

Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories

Multivariate Proteomic MS Disease Activity Test Score Performance Evaluated in an Independent Focal Inflammation Cohort

Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test

Improving Patient Outcomes through a Comprehensive Care Management Platform Measuring Outcomes and Value: an Integrated, Novel solution for Generating insights in MS (MOVING MS)

BrainGraph: A Novel Visualization of MRI Data as a 3D Graph to Reveal Temporal Features of Disease Progression In Patients with Multiple Sclerosis

High throughput lesion evaluation and quality control for incorporating quantitative imaging metrics into clinical practice

Multivariate protein biomarker models more accurately predict multiple sclerosis MRI disease activity compared to serum levels of neurofilament light chain alone

Classification of high versus low annualized relapse rate status in subjects with relapsing-remitting multiple sclerosis using multivariate serum protein biomarker models